NCT02215863 Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years Status COMPLETED Phase PHASE4
NCT02215252 A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN) Status COMPLETED Phase PHASE2
NCT02213757 Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH) Status TERMINATED Phase PHASE4
NCT02213263 A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) Status COMPLETED Phase PHASE3
NCT02213250 An Open-Label, Single Dose Pharmacokinetic Study of Benefix (Recombinant Factor IX) in Male Chinese Subjects With Hemophilia B Status COMPLETED Phase PHASE1
NCT02211261 A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT02208284 A Single Oral Dose Study Of PF-06427878 In Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT02207699 Evaluation of the Effect of Benzonatate on QT Intervals Following Single Dose Administration of Benzonatate to Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02207504 Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer Status COMPLETED Phase PHASE1
NCT02206607 Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus. Status COMPLETED Phase PHASE1
NCT02205476 A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study Status TERMINATED Phase PHASE2
NCT02202850 Defining Remission With Etanercept in AS in Real Life Clinical Practice Status COMPLETED Phase N/A
NCT02202837 Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice Status COMPLETED Phase N/A
NCT02202499 Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence Status COMPLETED Phase EARLY_PHASE1
NCT02202135 Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections. Status TERMINATED Phase PHASE3
NCT02201524 Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis Status TERMINATED Phase PHASE2
NCT02201511 A Healthy Volunteer Trial to Gain Information About the Blood Concentrations of PF-06412562 After Oral Administration of a Modified Release Formulation in Fasted and Fed Conditions Status COMPLETED Phase PHASE1
NCT02197130 Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease Status COMPLETED Phase PHASE2